JOURNAL CONTENT	JOURNAL PRACTICES	ORGANISATION	BUSINESS PRACTICES
1. Name of Journal 2. Website 3. Publishing schedule 4. Archiving 5. Copyright 6. Licensing	7. Publication ethics and related editorial policies 8. Peer review 9. Access	10. Ownership and management 11. Advisory body 12. Editorial team/contact information	13. Author fees 14. Other revenue 15. Advertising 16. Direct marketing

JOURNAL CONTENT

1. Name of journal

https://www.helicojournal.org/about/about.php

2. Website

• Website: https://www.helicojournal.org/
• Aims and scope: https://www.helicojournal.org/about/
• The target readership of the journal:
  The Korean Journal of Helicobacter and Upper Gastrointestinal Research (Korean J Helicobacter Up Gastrointest Res) is an international peer-reviewed open-access journal that publishes the latest research covering diverse topics for the diagnosis and treatment of a wide range of upper gastrointestinal disorders, including gastric cancer and Helicobacter pylori-related diseases. The journal introduces physicians, researchers, and general readers to the latest developments in upper gastrointestinal tract disorders, including the clinical phenomena associated with H. pylori and different microbiota and aims to contribute to a better understanding of various gastrointestinal diseases. This Korean-English bilingual journal publishes articles that discuss in-depth approaches to upper gastrointestinal diseases and aims to serve as an educational forum for exchange of ideas and opinions on upper gastrointestinaI diseases and also encourages research and publication.
• The types of manuscripts the journal will consider for publication: https://www.helicojournal.org/authors/authors.php
• Authorship criteria: https://www.helicojournal.org/authors/authors.php
• pISSN: 1738-3331 / eISSN: 2671-826X

3. Publishing schedule

The Korean J Helicobacter Up Gastrointest Res, the official journal of the Korean College of Helicobacter and Upper Gastrointestinal Research, is published on a quarterly basis on the 10th of March, June, September, and December.
https://www.helicojournal.org/authors/authors.php

4. Archiving

The full text of the Korean J Helicobacter Up Gastrointest Res has been archived in National Library of Korea (https://nl.go.kr), so readers can still access all articles even if the journal ceases publishing.

5. Copyright

The copyright of all manuscripts accepted for publication in the Korean J Helicobacter Up Gastrointest Res will be transferred to the Korean College of Helicobacter and Upper Gastrointestinal Research (https://www.hpylori.or.kr). The corresponding author should submit a “Copyright Transfer Form” (https://www.helicojournal.org/authors/copyright_transfer_agreement.php) through the online submission system after acceptance of the manuscript.

6. Licensing

• All articles in the Korean J Helicobacter Up Gastrointest Res are distributed under the CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/).
• To use figures/tables/videos or any data from the Korean J Helicobacter Up Gastrointest Res for commercial purposes, the authors should submit a request for permission to the editorial office (helicojournal@smileml.com or hpylori@kams.or.kr); permission will be granted by the Editor-in-Chief if appropriate. Data may be used with appropriate citation of the original source in cases of non commercial use.
• The authors should not submit their manuscript to other journals/publications once it is submitted to the Korean J Helicobacter Up Gastrointest Res. Authors may submit an article that has been published by a non-profit site (e.g., a university website, and arXiv, medRxiv, among others); however, this information should be specified in the cover letter, and the article should not be simultaneously submitted for peer review. Following publication in the Korean J Helicobacter Up Gastrointest Res, authors should update the non-profit site with the published article.
• All contents of the journal are available immediately upon publication without embargo period.

JOURNAL PRACTICES

7. Publication ethics and related editorial policies

1) Authorship and contributorship

• An author must have made substantial contributions to all of the following categories established by the ICMJE: (1) conception and design, acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be published, and (4) agreeing to be accountable for all aspects of the work to ensure that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Those who meet some, but not all authorship criteria should be mentioned in the acknowledgment section.
  Changes to authorship (addition or deletion of author names or rearranging the order of authors) after the initial submission of a manuscript are possible during the review process; however, the corresponding author should submit a letter signed by all authors to the editor to explain the rationale for these modifications. All authors must complete the copyright assignment. Any revision to authorship is not permitted after acceptance of the manuscript.
  The description of equal contributions, commonly indicated by co-first authors or co-corresponding authors, is permitted for up to two individuals. However, the equal contributions of the two authors should be explicitly explained to the editor in the cover letter submitted with the manuscript.
  The corresponding author is primarily responsible for communicating with the journal throughout the publication process (manuscript submission, peer review, and publication). The editorial board may request the corresponding author for details regarding authorship, ethics committee approval, clinical trial registration documentation, and conflict of interest statements.
• The contributions of all authors should be described based on the Contributor Roles Taxonomy (CRediT) authorship statement, which includes 14 roles: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing—original draft, and Writing—review & editing.

2) Complaints and appeals
     Authors and readers may contact freely regarding complaints and appeals to the editorial team. The editorial team will follow the COPE guideline (https://publicationethics.org/guidance/Flowcharts). For contact information, please see ‘12. Editorial team/contact information’ for details.

3) Allegations of research misconduct

• If the manuscript is not published in accordance with ethical policies, the authors will be notified, and sanctions may be imposed in accordance with the COPE guidelines (https://publicationethics.org/guidance/Flowcharts).
  The journal operates a Research Ethics Council to consider research ethics and related issues. The Director of the Publication Committee of the Korean College of Helicobacter and Upper Gastrointestinal Research chairs the Council, and the Publication Committee determines the Council’s constitution.
  The Research Ethics Council plays a key role in (1) reviewing research ethics issues (any fabrication, falsification, plagiarism, duplication, wrongful research paper author indication, or multiple/duplicate publication allegations) associated with publication of the journal and related papers (review articles, original articles, and others), and (2) reporting the results of the review to the Executive Committee of the Korean College of Helicobacter and Upper Gastrointestinal Research.

4) Conflicts of interest

• At the time of manuscript submission, authors should disclose any financial and personal relationships with other individuals or organizations that could affect their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. A potential conflict of interest should be disclosed in the manuscript, even when the authors are confident that their judgments have not affected preparation of the manuscript.
  The disclosure form should be the same as the ICMJE Uniform Disclosure Form for Potential Conflicts of Interest (http://www.icmje.org/conflicts-of-interest/), and it should be submitted by the corresponding author through the online submission system after acceptance of the manuscript.
• If the editor is one of the co-authors, he/she will not participate in the editorial evaluation or decision-making for publication of the manuscript.

5) Data sharing and reproducibility
     For clinical trials, the data-sharing statement should be added to the title page. The Korean J Helicobacter Up Gastrointest Res follows the ICMJE Recommendations for the data sharing statement policy (https://icmje.org/icmje-recommendations.pdf). Authors are required to identify the data, including patient information, a data dictionary that defines each field in the dataset, and supporting documentation (e.g., statistical/analytic code), which will be made available to others, including the following details: when, where, and how the data will be available (e.g., a link to a data repository), types of analyses permitted, and restrictions, if any, with regard to the use of the data. Authors are permitted to explain the rationale for not sharing data.

6) Ethical oversight
     Please refer to following URL for details: https://www.helicojournal.org/authors/ethics.php.

7) Intellectual property
     Please refer to following URL for details:
     https://www.helicojournal.org/authors/authors.php
     https://www.helicojournal.org/authors/ethics.php

8) Post-publication discussions, corrections, and retractions
     If there are any concerns about post publication, the editorial board will not hesitate to correct, revise, or retract articles, so please submit the queries to editorial team by email or submit the letter to the editor by submission website (https://submit.helicojournal.org/). Please refer to following URL for details: https://www.helicojournal.org/authors/ethics.php. For contact information, please see ‘12. Editorial team/contact information’ for details.

8. Peer review

• Submitted manuscripts are initially evaluated by the editorial office for completeness before the manuscript is assigned to a handling editor. Modifications/corrections may be requested at this stage before commencement of the peer review process.
• The journal performs a double-blinded peer review of submitted manuscripts. Neither peer reviewers’ nor authors’ identities are shared with each other. At least two reviewers with relevant subject area expertise perform a blind review of all manuscripts. Authors suggest preferred reviewers at the time of manuscript submission; however, the eventual selection of reviewers is at the discretion of the Editor-in-Chief. Based on the results of the peer review, the editorial board decides whether the manuscript merits publication and may request manuscript revisions. If the editor is an author, the manuscript is handled by a different editor and the editor/author does not participate in the editorial evaluation or decision-making to publish the manuscript.
• The editor’s decision regarding acceptance, rejection, or requests for major/minor revisions is communicated to the corresponding author. Following revision, manuscripts are reviewed to ensure that authors have complied with the journal’s instructions to authors. During the peer review process, editors may rephrase or format the manuscript but without altering the original meaning.
  Authors can submit supplementary materials for online-only publication, in cases in which adequate space is unavailable to include all material within the main document. Supplementary materials will also be peer-reviewed.
• Reviewers are typically expected to complete the peer review within 2 weeks after accepting the invitation to review a manuscript. However, reviewers can request for an extension under unavoidable circumstances. Authors will be notified immediately by the editorial office in such an event, which may result in a delay in the review process. If the review process is unduly prolonged, authors may decide to withdraw their manuscript and resubmit it to another journal.
  The authors may request withdrawal of their submitted manuscript at any time prior to formal acceptance of the article for publication. However, if a manuscript has already entered the “under review” status, it cannot be resubmitted after withdrawal. If however, the regular review schedule (2 weeks) is delayed, authors are immediately notified by the editorial office and under these circumstances, they may opt to withdraw their manuscript.
• All manuscripts are peer-reviewed regardless of article type.
• When requested, authors should revise the manuscript based on reviewers’ comments. Authors should upload their revised manuscript within one month of receiving the editorial decision. In the absence of a response from the corresponding author regarding the revised manuscript within one month, it is considered withdrawal of the manuscript, and the review process is terminated. For revisions, authors should mark the main document and supplementary tables using the track changes function in Microsoft Word, highlights, color fonts, and other such features and should suggest responses to reviewers.
• After acceptance, the manuscript proofs will be sent to the corresponding author(s) for approval and these should be returned to the publisher within 48 working hours. The manuscript will be published after final confirmation from the corresponding author. Any errors detected in the manuscript thereafter are the responsibility of the author(s), and these should be corrected as a corrigendum.

Please refer to following URL for details: https://www.helicojournal.org/authors/authors.php

9. Access

• The Korean J Helicobacter Up Gastrointest Res is the official journal of the Korean College of Helicobacter and Upper Gastrointestinal Research. It is an international peer-reviewed open-access journal and full text is freely available at https://www.helicojournal.org/.
• If offline version (print version) is required, please contact to the editorial office (helicojournal@smileml.com or hpylori@kams.or.kr). The extra charge will not be requested.

ORGANISATION

10. Ownership and management

• The copyright of all manuscripts accepted for publication in the Korean J Helicobacter Up Gastrointest Res will be transferred to the Korean College of Helicobacter and Upper Gastrointestinal Research (https://www.hpylori.or.kr). The corresponding author should submit a “Copyright Transfer Form” (https://www.helicojournal.org/authors/copyright_transfer_agreement.php) through the online submission system after acceptance of the manuscript.
• The detailed information about the management team is suggested at https://www.helicojournal.org/about/management_team.php.
• For contact information, please see ‘12. Editorial team/contact information’ for details.

11. Advisory body

• For detailed information, please refer to following URL: https://www.helicojournal.org/about/editorial.php

12. Editorial team/contact information

• For detailed information, please refer to following URL:
  https://www.helicojournal.org/about/contact.php

Contact us

Editor-in-Chief: Soo-Jeong Cho, MD, PhD
Seoul National University, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
E-mail: crystal5@snu.ac.kr

Editorial Office
The Korean College of Helicobacter and Upper Gastrointestinal Research
Lotte Gold Rose II Room 917, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-717-5543
E-mail: helicojournal@smileml.com
                hpylori@kams.or.kr

BUSINESS PRACTICES

13. Author fees

• The Korean J Helicobacter Up Gastrointest Res does not charge readers and authors any fee, such as article processing charges, page charges, editorial processing charges, language editing fees, color charges, submission fees, or subscription fees. Authors can sign in on the submission website (https://submit.helicojournal.org) without any payment. The full text is freely available at https://www.helicojournal.org.

14. Other revenue

• The Korean J Helicobacter Up Gastrointest Res is mainly supported by the publisher, the Korean College of Helicobacter and Upper Gastrointestinal Research. This journal is also supported by the Korean Federation of Science and Technology Societies (KOFST) grant, funded by the Korean Government, and advertising rates. The Korean J Helicobacter Up Gastrointest Res does not provide reprint service. The editorial boards’ decision will not be influenced by the revenue sources.
  This academic journal and the advertisement price follow the Korean Research-based Pharma Industry Association (KRPIA) (https://www.krpia.or.kr/board/select/fairRule/100382) and Korean Medical Devices Industry Association (KMDIA) (http://www.kmdia.or.kr/KO/document/business/justice01.asp).

15. Advertising

• The editorial boards’ decision will not be influenced by the advertisements.
• The Korean J Helicobacter Up Gastrointest Res accepts advertisements based on the following:
  1) Eligibility of the advertised products or services

  All products or services should be safe and reliable and not cause any harm to the health and welfare of humans. Advertisements can promote information and technologies relevant to authors, editors, reviewers, and readers. Pharmaceutical products, medical devices, and other services can be considered.
  Advertising is separate from content. Advertisers and sponsors have no advanced knowledge of our editorial contents, nor do the editors have advanced knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors have no input on any of our editorial decisions or advertising policies. We reserve the right to decline or cancel any advertisement at any time. Advertisements for pharmaceutical products and medical devices must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea, in every respect.

  2) Orders

  The acceptance of advertisements will be discussed by the editorial board and will be ultimately approved by the publisher (President of the Korean College of Helicobacter and Upper Gastrointestinal Research).

  3) Advertisement fee
  

  This academic journal and the advertisement price follow the KRPIA (https://www.krpia.or.kr/board/select/fairRule/100382) and KMDIA (http://www.kmdia.or.kr/KO/document/business/justice01.asp).

  4) Liability
  

  Neither the publisher nor the editors will be legally liable for advertisements presented in the journal. In addition, they cannot guarantee the accuracy, completeness, or usefulness of the information provided.

  5) Endorsement
  

  The publisher and editors do not endorse any advertised products or services.

  6) Disclaimer
  

  Neither the publisher nor the authors will be legally liable for any of the content of advertisements, and readers must keep this in mind when viewing advertisements.

16. Direct marketing

• Journal propagation is done through the Korean J Helicobacter Up Gastrointest Res website and the distribution of an introduction pamphlet during the related conferences organized by the Korean College of Helicobacter and Upper Gastrointestinal Research. Invitations to submit a manuscript are usually focused on presenters at conferences, seminars, or workshops, if the topic is related to the journal’s aims and scope.